SLC13A2 and neoplasm: In another parallel study from our group, we also found that SLC13A2-transported citrate releases acetyl-CoA to suppress tumor growth through the acetylation and degradation of a key glycolytic enzyme pyruvate kinase muscle isozyme M2 (PKM2) (Qin et al, 2024).